Zorlu F - Search Results

1

Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients.

Akdogan B, Divrik RT, Tombul T, Yazici S, Tasar C, Zorlu F, Ozen H. Akdogan B, et al. Among authors: zorlu f. J Urol. 2007 Jul;178(1):129-33; discussion 133. doi: 10.1016/j.juro.2007.03.027. Epub 2007 May 17. J Urol. 2007. PMID: 17499297

2

The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.

Divrik RT, Yildirim U, Zorlu F, Ozen H. Divrik RT, et al. Among authors: zorlu f. J Urol. 2006 May;175(5):1641-4. doi: 10.1016/S0022-5347(05)01002-5. J Urol. 2006. PMID: 16600720 Clinical Trial.

3

Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?

Divrik RT, Akdoğan B, Ozen H, Zorlu F. Divrik RT, et al. Among authors: zorlu f. J Urol. 2006 Oct;176(4 Pt 1):1424-29; discussion 1429-30. doi: 10.1016/j.juro.2006.06.012. J Urol. 2006. PMID: 16952649

4

The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.

Divrik RT, Sahin A, Altok M, Unlü N, Zorlu F. Divrik RT, et al. Among authors: zorlu f. J Urol. 2007 Sep;178(3 Pt 1):802-6; discussion 806. doi: 10.1016/j.juro.2007.05.054. Epub 2007 Jul 16. J Urol. 2007. PMID: 17632171

5

Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?

Divrik T, Yildirim U, Eroğlu AS, Zorlu F, Ozen H. Divrik T, et al. Among authors: zorlu f. J Urol. 2006 Apr;175(4):1258-61. doi: 10.1016/S0022-5347(05)00689-0. J Urol. 2006. PMID: 16515974 Clinical Trial.

6

Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.

Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H. Divrik RT, et al. Among authors: zorlu f. Urol Oncol. 2007 Sep-Oct;25(5):376-82. doi: 10.1016/j.urolonc.2006.08.028. Urol Oncol. 2007. PMID: 17826653

7

Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial.

Divrik RT, Sahin AF, Yildirim U, Altok M, Zorlu F. Divrik RT, et al. Among authors: zorlu f. Eur Urol. 2010 Aug;58(2):185-90. doi: 10.1016/j.eururo.2010.03.007. Epub 2010 Mar 19. Eur Urol. 2010. PMID: 20303646 Clinical Trial.

8

Benign intrascrotal lesion: fibrous pseudotumor of testis.

Tarhan H, Divrik RT, Akarken I, Altok M, Zorlu F. Tarhan H, et al. Among authors: zorlu f. Arch Ital Urol Androl. 2011 Jun;83(2):105-7. Arch Ital Urol Androl. 2011. PMID: 21826885

9

Prostate cancer incidence in Turkey: an epidemiological study.

Zorlu F, Zorlu R, Divrik RT, Eser S, Yorukoglu K. Zorlu F, et al. Among authors: zorlu r. Asian Pac J Cancer Prev. 2014;15(21):9125-30. doi: 10.7314/apjcp.2014.15.21.9125. Asian Pac J Cancer Prev. 2014. PMID: 25422189 Free article.

10

Factors determining biochemical recurrence in low-risk prostate cancer patients who underwent radical prostatectomy.

Ün S, Türk H, Koca O, Divrik RT, Zorlu F. Ün S, et al. Among authors: zorlu f. Turk J Urol. 2015 Jun;41(2):61-6. doi: 10.5152/tud.2015.65624. Turk J Urol. 2015. PMID: 26328203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page